[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Nonalcoholic Fatty Liver Disease Market Report 2016

September 2016 | 126 pages | ID: E00CC8A651BEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Nonalcoholic Fatty Liver Disease

Revenue, means the sales value of Nonalcoholic Fatty Liver Disease

This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Conatus Pharmaceuticals
  • Daewoong Pharmaceutical
  • Galmed International
  • Kyorin Pharmaceutical
  • Metabolic Solutions Development
  • Novartis AG
  • Phenex Pharmaceuticals
  • Raptor Pharmaceuticals
  • TCM Biotech International
  • Tobira Therapeutics
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nonalcoholic Fatty Liver Disease in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Nonalcoholic Fatty Liver Disease Market Report 2016

1 NONALCOHOLIC FATTY LIVER DISEASE OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Nonalcoholic Fatty Liver Disease
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Nonalcoholic Fatty Liver Disease Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)
  1.5.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
  1.5.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

2 EUROPE NONALCOHOLIC FATTY LIVER DISEASE BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers
  2.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Type
  2.2.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
2.3 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Countries
  2.3.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)
2.4 Europe Nonalcoholic Fatty Liver Disease (Volume) by Application

3 GERMANY NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  3.1.1 Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  3.1.2 Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
3.2 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
3.3 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
3.4 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

4 FRANCE NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

4.1 France Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  4.1.1 France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  4.1.2 France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  4.1.4 France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
4.2 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
4.3 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
4.4 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

5 UK NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

5.1 UK Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  5.1.1 UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  5.1.2 UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  5.1.5 UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
5.2 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
5.3 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
5.4 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

6 RUSSIA NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  6.1.1 Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  6.1.2 Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
6.2 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
6.3 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
6.4 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

7 ITALY NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  7.1.1 Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  7.1.2 Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
7.2 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
7.3 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
7.4 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

8 SPAIN NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  8.1.1 Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  8.1.2 Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
8.2 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
8.3 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
8.4 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

9 BENELUX NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
  9.1.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
9.2 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
9.3 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
9.4 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

10 EUROPE NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS ANALYSIS

10.1 Conatus Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Daewoong Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Galmed International
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Kyorin Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Metabolic Solutions Development
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Novartis AG
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Phenex Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Raptor Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 TCM Biotech International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Tobira Therapeutics
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURING COST ANALYSIS

11.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE NONALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2016-2021)

14.1 Germany Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.2 France Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.3 UK Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.4 Russia Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.5 Italy Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.6 Spain Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.7 Benelux Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.8 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
14.9 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure Europe Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Countries (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Application (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Table Nonalcoholic Fatty Liver Disease Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories